{"brief_title": "Assessment of Potential Interactions Between Methamphetamine and Selegiline - 1", "brief_summary": "The purpose of this study is to assess the potential interactions between intravenous methamphetamine and oral selegiline.", "detailed_description": "To determine the safety of the selegiline concurrent with d-methamphetamine challenges of 15mg & 30mg i.v. with the focus being on cardiovascular responses (HR,BP) to the i.v. methamphetamine challenges. This is a randomized, single-blind, placebo-controlled, two-arm study design to evaluate the safety of selegiline treatment, compared to placebo treatment, concurrent with i.v. methamphetamine challenges.", "condition": "Amphetamine-Related Disorders", "intervention_type": "Drug", "intervention_name": "Selegiline", "criteria": "Inclusion Criteria: - Volunteers who meet DSM-4 criteria for methamphetamine abuse or dependence; non-treatment seeking individuals - Be able to verbalize understanding of consent form; provide written informed consent Exclusion Criteria: - Please contact site for more information", "gender": "All", "minimum_age": "18 Years", "maximum_age": "45 Years", "healthy_volunteers": "No", "id": "NCT00033072.xml"}